$20.00
arrow_drop_up7.75%Key Stats | |
---|---|
Open | $19.30 |
Prev. Close | $18.56 |
EPS | -1.29 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 19.23 | 21.00 |
52 Week Range | 13.16 | 21.00 |
Ratios | |
---|---|
EPS | -1.29 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Why Bausch + Lomb Rallied Today
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say
Nicox announces attendance at upcoming conferences - GlobeNewswire
Nicox appoints experienced biotech leader Damian Marron as Chair of the Board and Marc Le Bozec as Director - GlobeNewswire